Top Tweets for #LBA17
Dear Colleagues,
The @OncoAlert 🚨Network Presents OUR Picks of TOP 🔟Abstracts to be Presented at #ESMO24
This List Curated by: #OncoAlertAF Leads
@ElisaAgostinett 🇮🇹
@to_be_elizabeth 🇮🇹
@Lucarecco 🇮🇹
@weoncologists 🇺🇸
With our distinguished OncoAlert Faculty:
@stolaney1 🇺🇸@E_de_Azambuja 🇧🇪@hoperugo 🇺🇸@matteolambe 🇮🇹@Icro_Meattini 🇮🇹& @kevinpunie 🇧🇪
LBA4 Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for high-risk early-stage TNBC: Overall survival results from the phase 3 KEYNOTE-522 study. Peter Schmid (London, United Kingdom🇬🇧)- Discussant @lab_kok
Date: Sun, 15.09.2024
Time 16:30 - 16:42
LBA13 Adjuvant Ribociclib (RIB) Plus Nonsteroidal Aromatase Inhibitor (NSAI) in Patients (Pts) With HR+/HER2− Early Breast Cancer (EBC): 4-Year Outcomes from the NATALEE Trial. Peter A. Fasching (Erlangen, Germany🇩🇪)
Date: Mon, 16.09.2024
Time 11:15 - 11:25
LBA18 Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2+ advanced/metastatic breast cancer (mBC) with or without brain metastases (BM): DESTINYBreast-12 primary results. @nlinmd (Boston, United States of America🇺🇸 @DanaFarber ) Discussant Cristina Laura of @VHIO
Date: Fri, 13.09.2024
Time: 16:00 - 16:10
LBA19 Capivasertib (C) + paclitaxel (P) as first-line treatment of metastatic triple-negative breast cancer (mTNBC): the CAPItello-290 Phase 3 trial @hmcarthur (Dallas, United States of America🇺🇸 @UTSWMedCenter )
Date: Fri, 13.09.2024
Time: 16:45 - 16:55
LBA21 Human epidermal growth factor receptor 2 (HER2)-low and HER2-ultralow status determination in tumors of patients (pts) with hormone receptor–positive (HR+) metastatic breast cancer (mBC) in DESTINY-Breast06 (DB-06). Giuseppe Viale (Milan, Italy🇮🇹 @IEOufficiale )Discussant @c_sotiriou of @JulesBordet
Date: Sun, 15.09.2024
Time: 08:40 - 8:50
LBA23 ABIGAIL: Randomized phase II study of abemaciclib plus endocrine therapy (ET) with or without a short course of induction paclitaxel in patients (pts) with previously untreated HR-positive/HER2-negative advanced breast cancer (HR+/HER2- ABC) with aggressive disease criteria. Juan De la Haba Rodriguez (Cordoba, Spain🇪🇸)
Date: Mon, 16.09.2024
Time: 09:00 - 9:20
236MO Pathologic complete response and survival after neoadjuvant chemotherapy in stage I TNBC: A registry-based study @Manon_deGraaf (Amsterdam, Netherlands🇳🇱) Discussant @DrLisaCarey
Date: Sat, 14.09.2024
Time: 10:45 - 10:50
LBA10 - Primary endpoint results of the Neo-CheckRay phase II trial evaluating stereotactic body
radiation therapy (SBRT) +/- durvalumab (durva) +/- oleclumab (ole) combined with neo-
adjuvant chemotherapy (NACT) for early-stage, high risk ER+/HER2- breast cancer (BC) @AlexDeCaluwe (Brussels, Belgium🇧🇪)
Date: Mon, 16.09.2024
Time : 10:55 - 11:05
LBA17 - Survival outcome of neoadjuvant endocrine therapy + trastuzumab and pertuzumab (ET+T+P) vs. de-escalated chemotherapy (CT)+T+P in hormone receptor positive (HR+)/HER2+early breast cancer (EBC): WSG-TP-II trial Oleg Gluz (Mönchengladbach, Germany🇩🇪)
Date: Sat, 14.09.2024
Time : 10:15 - 11:55
232O - Effects of a high-intensity exercise intervention on recurrence and survival: The OptiTrain breast cancer trial @HHeleneru (Stockholm, Sweden🇸🇪)
Date: Mon, 16.09.2024
Time: 10:25 - 10:35
Ping #BreastCancer Faculty
@DrSGraff @ErikaHamilton9 @double_whammied @maryam_lustberg @IBCResearch @raalbany @JaniceTNBCmets
#OncoAlertAF
@nataliagandur @acampsmalea @BiagioRicciutMD
@yekeduz_emre @HHorinouchi @FadiHaddad_MD
@Dr_Ivanoncologo @Abdallah81MD @FernandoOnco
@ElisaAgostinett @to_be_elizabeth @lungoncdoc @bavilima @realbowtiedoc @Erman_Akkus @DrFMartinelli @Lucarecco @orellanauro

HALL OF FAME AWARD
Congratulations to Mary Sweeney of @Castlegrovehse the recipient of the prestigious #LKBA17 Hall of Fame Award. Sponsored by @CoDerryAirport

Works over for today time to get suited and booted for tonight’s awards #LBA17 @lkchamber looking forward to it. @JimmystaffordDJ @DavittWalsh1 best of luck to all.
We are up for excellence in marketing at the #LBA17 follow the link and give the @Lemontree_lk a tick.. #donegalfood https://t.co/6UvB6qxztA
We're nominated for the #LBA17 Best Social Enterprise Award so if you'd like to vote for us you can do so here: https://t.co/vYxN6FzCpc
We have been nominated for the #LBA17 Excellence in marketing follow the link and give us a wee vote it would be very much appreciated. #donegalfood @Chrismolloy_ https://t.co/6RbhbhjlnQ
Voting for the #LBA17 Excellence in Marketing Award is now open. Back your favourite today! @lkchamber https://t.co/nD4Ubd8xVP

Voting for the #LBA17 Excellence in Customer Service Award is now open. Back your favourite today! @lkchamber https://t.co/LSIHEWa0RG

Voting for the #LBA17 Best Social Enterprise Award is now open. Back your favourite today! @lkchamber https://t.co/Lll8qj5ajd

Voting for the #LBA17 Best Social Enterprise Award is now open. Back your favourite today! @lkchamber https://t.co/Lll8qj5ajd

Voting for the #LBA17 Excellence in Marketing Award is now open. Back your favourite today! @lkchamber https://t.co/nD4Ubd8xVP

So excited to be heading to @CarrickdaleHote for @DundalkChamber #LBA17 tonight. Best of luck to everyone #louthchat #volunteerlouth

RT @Igniterecruit: RT @CDC_Events: Congratulations to our client @SamlesburyHotel for being short listed in the #LBA17 awards! #awards #Tou…
Congratulations to our client @SamlesburyHotel for being short listed in the #LBA17 awards! #awards #Tourism #Lancashire
@LBA_Bisceglie, si parte con @magdicristiano, @paskampo e @sergio_pirozzi https://t.co/oBeTOjdvC2 #Bisceglie24 #LBA17 #LBA8
Libri nel Borgo Antico prende forma 😊
#LBA8 #LBA17 #workinprogress @ Bisceglie https://t.co/JZP8mkTeWA
Alle ore 20 di oggi si chiudono le iscrizioni per partecipare come #volontario a Libri nel Borgo Antico: ragazzi affrettatevi 😉
#LBA8 #LBA17
I nostri più sinceri auguri a @paskampo, nuovo Community Manager @acmilan .
Sarà nostro ospite con #Nerosurosso
#anteprima #autori #LBA17

Talking #Lancashire narrative and bringing the Lancashire #lifestyle to the fore
@DIBLancs with the #LBA17 award winners @HolidayInn Preston

Last Seen Hashtags on Sotwe
Most Popular Users

Elon Musk 
@elonmusk
241.2M followers

Barack Obama 
@barackobama
119.1M followers

Cristiano Ronaldo 
@cristiano
112.9M followers

Donald J. Trump 
@realdonaldtrump
111.8M followers

Narendra Modi 
@narendramodi
107.1M followers

Rihanna 
@rihanna
98.3M followers

NASA 
@nasa
92.3M followers

Justin Bieber 
@justinbieber
91.5M followers

KATY PERRY 
@katyperry
89.1M followers

Taylor Swift 
@taylorswift13
83M followers

Lady Gaga 
@ladygaga
74.5M followers

Virat Kohli 
@imvkohli
72M followers

Kim Kardashian 
@kimkardashian
70.5M followers

YouTube 
@youtube
68.8M followers

Neymar Jr 
@neymarjr
64.9M followers

Bill Gates 
@billgates
64.6M followers

The Ellen Show
@theellenshow
62.4M followers

Selena Gomez 
@selenagomez
62.1M followers

CNN 
@cnn
61.8M followers

X 
@x
60.8M followers















